Gene · 4821
NIH grants1,452
NIH grants whose papers are about the gene, through NIH's grant-paper links.
561 to 580 of 1,452
Download this page as JSON| Grant | Title | NKX2-2 papers | Newest fiscal year |
|---|---|---|---|
| R01DK106236 | Beyond GWAS of insulin resistance: An integrated approach to translate genetic association to function | 1 | 2020 |
| R01DK108905 | ChREBP Isoforms in Pancreatic Beta Cells | 1 | 2020 |
| R01GM030518 | Computer Studies of Protein Structure and Function | 1 | 2020 |
| R01GM050877 | Structure and function of stress fibers and cell adhesion sites | 1 | 2020 |
| R01GM067858 | A Comprehensive Resource for Manipulating the Drosophila Genome | 1 | 2020 |
| R01HD087566 | Regenerating CNS white matter using induced pluripotent stem cells | 1 | 2020 |
| R01MH066912 | Generating and accelerating the maturation of Pvalb-fast spiking interneurons from human stem cells | 1 | 2020 |
| R01NS045523 | Molecular Controls over Neurogenesis, Subtype Development, and Diversity of Cortical Output Projection Neurons | 1 | 2020 |
| R01NS070577 | Human iPSC-based personalized cell therapy of PD | 1 | 2020 |
| R01NS091544 | Long noncoding RNA regulation of neural stem cells | 1 | 2020 |
| R01NS092616 | Induced Adult Neurogenesis for Parkinson's Disease | 1 | 2020 |
| R01NS096148 | MicroRNAs as critical regulators of remyelination in Multiple Sclerosis | 1 | 2020 |
| R01NS097195 | Glutaminase and its neurotoxic link to HAND | 1 | 2020 |
| R03AG063287 | Genetic interaction of PICALM and APOE in Alzheimer's disease | 1 | 2020 |
| R21AA027827 | Modeling poly-genomic risk in the relationship between brain structure and alcohol involvement from adolescence through adulthood | 1 | 2020 |
| R21AG062948 | Evolutionary Conserved Mechanisms of Neuronal Degeneration and Regeneration | 1 | 2020 |
| R21AG066090 | The molecular mechanism of PICALM-dependent endosomal trafficking | 1 | 2020 |
| R21CA234979 | Targeting EWS-FLI1 protein stability as therapeutic strategy for Ewing sarcoma | 1 | 2020 |
| R21DA046791 | Cannabis Use and its Medical Risks and Benefits: Leveraging Mobile Technology and Consumer Genomics | 1 | 2020 |
| R21DA047527 | Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4821/grants?page=29